Cargando…
Epidemiology and treatment outcomes in pediatric patients with post-injection paralysis
BACKGROUND: Post-injection paralysis (PIP) of the sciatic nerve is an iatrogenic paralysis that occurs after an intramuscular injection, with resultant foot deformity and disability. This study investigates the epidemiology and treatment of PIP in Uganda. METHODS: Health records of pediatric patient...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9354298/ https://www.ncbi.nlm.nih.gov/pubmed/35932071 http://dx.doi.org/10.1186/s12891-022-05664-4 |
_version_ | 1784763037204348928 |
---|---|
author | Song, Siyou Muhumuza, Moses Fisha Penny, Norgrove Sabatini, Coleen S. |
author_facet | Song, Siyou Muhumuza, Moses Fisha Penny, Norgrove Sabatini, Coleen S. |
author_sort | Song, Siyou |
collection | PubMed |
description | BACKGROUND: Post-injection paralysis (PIP) of the sciatic nerve is an iatrogenic paralysis that occurs after an intramuscular injection, with resultant foot deformity and disability. This study investigates the epidemiology and treatment of PIP in Uganda. METHODS: Health records of pediatric patients surgically treated for PIP at the CoRSU Rehabilitation Hospital from 2013 to 2018 were retrospectively reviewed. Pre-operative demographics, perioperative management, and outcomes were coded and analyzed with descriptive statistics, chi-square for categorical variables, and linear models for continuous variables. RESULTS: Four-hundred and two pediatric patients underwent 491 total procedures. Eighty-three percent of reported injection indications were for febrile illness. Twenty-five percent of reported injections explicitly identified quinine as the agent. Although ten different procedures were performed, achilles tendon lengthening, triple arthrodesis, tibialis posterior and anterior tendon transfers composed 83% of all conducted surgeries. Amongst five different foot deformities, equinus and varus were most likely to undergo soft tissue and bony procedures, respectively (p=0.0223). Ninteen percent of patients received two or more surgeries. Sixty-seven percent of patients achieved a plantigrade outcome; 13.61% had not by the end of the study period; 19.3% had unreported outcomes. Those who lived further from the facility had longer times between the inciting injection and initial hospital presentation (p=0.0216) and were more likely to be lost to follow-up (p=0.0042). CONCLUSION: PIP is a serious iatrogenic disability. Prevention strategies are imperative, as over 400 children required 491 total surgical procedures within just six years at one hospital in Uganda. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12891-022-05664-4. |
format | Online Article Text |
id | pubmed-9354298 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-93542982022-08-06 Epidemiology and treatment outcomes in pediatric patients with post-injection paralysis Song, Siyou Muhumuza, Moses Fisha Penny, Norgrove Sabatini, Coleen S. BMC Musculoskelet Disord Research BACKGROUND: Post-injection paralysis (PIP) of the sciatic nerve is an iatrogenic paralysis that occurs after an intramuscular injection, with resultant foot deformity and disability. This study investigates the epidemiology and treatment of PIP in Uganda. METHODS: Health records of pediatric patients surgically treated for PIP at the CoRSU Rehabilitation Hospital from 2013 to 2018 were retrospectively reviewed. Pre-operative demographics, perioperative management, and outcomes were coded and analyzed with descriptive statistics, chi-square for categorical variables, and linear models for continuous variables. RESULTS: Four-hundred and two pediatric patients underwent 491 total procedures. Eighty-three percent of reported injection indications were for febrile illness. Twenty-five percent of reported injections explicitly identified quinine as the agent. Although ten different procedures were performed, achilles tendon lengthening, triple arthrodesis, tibialis posterior and anterior tendon transfers composed 83% of all conducted surgeries. Amongst five different foot deformities, equinus and varus were most likely to undergo soft tissue and bony procedures, respectively (p=0.0223). Ninteen percent of patients received two or more surgeries. Sixty-seven percent of patients achieved a plantigrade outcome; 13.61% had not by the end of the study period; 19.3% had unreported outcomes. Those who lived further from the facility had longer times between the inciting injection and initial hospital presentation (p=0.0216) and were more likely to be lost to follow-up (p=0.0042). CONCLUSION: PIP is a serious iatrogenic disability. Prevention strategies are imperative, as over 400 children required 491 total surgical procedures within just six years at one hospital in Uganda. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12891-022-05664-4. BioMed Central 2022-08-05 /pmc/articles/PMC9354298/ /pubmed/35932071 http://dx.doi.org/10.1186/s12891-022-05664-4 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Song, Siyou Muhumuza, Moses Fisha Penny, Norgrove Sabatini, Coleen S. Epidemiology and treatment outcomes in pediatric patients with post-injection paralysis |
title | Epidemiology and treatment outcomes in pediatric patients with post-injection paralysis |
title_full | Epidemiology and treatment outcomes in pediatric patients with post-injection paralysis |
title_fullStr | Epidemiology and treatment outcomes in pediatric patients with post-injection paralysis |
title_full_unstemmed | Epidemiology and treatment outcomes in pediatric patients with post-injection paralysis |
title_short | Epidemiology and treatment outcomes in pediatric patients with post-injection paralysis |
title_sort | epidemiology and treatment outcomes in pediatric patients with post-injection paralysis |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9354298/ https://www.ncbi.nlm.nih.gov/pubmed/35932071 http://dx.doi.org/10.1186/s12891-022-05664-4 |
work_keys_str_mv | AT songsiyou epidemiologyandtreatmentoutcomesinpediatricpatientswithpostinjectionparalysis AT muhumuzamosesfisha epidemiologyandtreatmentoutcomesinpediatricpatientswithpostinjectionparalysis AT pennynorgrove epidemiologyandtreatmentoutcomesinpediatricpatientswithpostinjectionparalysis AT sabatinicoleens epidemiologyandtreatmentoutcomesinpediatricpatientswithpostinjectionparalysis |